CEACAM8 and type 2 diabetes mellitus: The expression of CD11b and CD66b activation markers on monocytes and neutrophils is increased in T2DM patients, promoting and increasing the adhesive capacity of neutrophils and monocytes to the endothelium and enhancing vascular and systemic damage [30].